Caribou Biosciences, Inc. (CRBU)
1.70
-0.02
(-1.16%)
USD |
NASDAQ |
Dec 26, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Total Assets (Quarterly): 194.98M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 51.56M |
| GT Biopharma, Inc. | 4.321M |
| Phio Pharmaceuticals Corp. | 11.50M |
| Daré Bioscience, Inc. | 30.75M |
| Nurix Therapeutics, Inc. | 522.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 53.14M |
| Shareholders Equity (Quarterly) | 141.84M |
| Debt to Equity Ratio | 0.1795 |
| Current Ratio | 5.542 |
| Net Debt Paydown Yield | 0.17% |